Aterian, Inc. Form 8-K Summary
Business Context and Reporting Period
Filed December 27, 2021, reporting events occurring primarily on December 22, 2021. Aterian entered into a new senior secured revolving credit facility, repaid and terminated its prior senior secured notes, and issued a warrant to the new financing provider.
Financing Terms and Key Metrics
- New facility: Revolving credit facility with commitments of up to $40.0 million, subject to a borrowing base based principally on inventory and sales receivables, including reserves.
- Initial use of proceeds: $27.6 million of net proceeds was used to repay all amounts outstanding under the terminated High Trail notes.
- Interest: 5.50% per annum plus, at the Company’s option, either a base rate or LIBOR.
- Undrawn commitment fee: 0.50% on the undrawn portion, generally based on average daily usage during the preceding fiscal quarter.
- Amortization: The facility requires no scheduled amortization payments.
- Liquidity: Remaining borrowing capacity is intended for working capital and general corporate purposes. The agreement requires the Company and its subsidiaries to maintain either a minimum liquidity level or minimum availability; the filing does not provide the applicable threshold.
- Prior notes: The $110.0 million initial-principal High Trail senior secured notes were fully repaid and terminated. The Company also paid an early redemption fee equal to 10.0% of the then-outstanding principal balance; the filing does not state the resulting dollar amount.
- Warrant: MidCap Funding XXVII Trust received a warrant to purchase up to 200,000 shares at $4.70 per share. The warrant is immediately exercisable, expires ten years after issuance, and may be exercised for cash or on a cashless basis.
Material Changes Versus the Prior Comparable Position
- The Company replaced its prior asset-secured High Trail notes with a new senior secured revolving facility.
- Liens and security interests granted under the terminated notes were released upon repayment.
- The new facility creates senior secured obligations that rank senior to all other Company indebtedness and is secured by a borrowing base involving inventory and receivables.
- The Company incurred potential equity dilution through the warrant issuance, representing up to 200,000 shares before adjustments.
Guidance, Covenants, Risks, and Unusual Items
- The Credit Agreement contains customary affirmative and negative covenants, including restrictions on additional indebtedness, liens, investments, dividends, and other distributions, subject to specified exceptions.
- Events of default include customary provisions, including a change-of-control event, which could accelerate obligations.
- The facility is subject to borrowing-base availability, reserves, liquidity or availability requirements, and lender-imposed restrictions, which may constrain operating flexibility.
- The warrant and underlying shares were issued in an unregistered transaction relying on Section 4(a)(2) and Rule 506(b) of Regulation D. The securities are restricted absent registration or an applicable exemption.
- The filing provides no revenue, profit, cash-flow, margin, or period-end balance-sheet data.
Investor Verification Priorities
- Verify the final amount outstanding, borrowing-base availability, and remaining unused capacity under the new facility.
- Review the complete Credit and Security Agreement for covenant thresholds, reserves, collateral terms, interest-rate mechanics, and events of default.
- Confirm the dollar amount of the 10.0% early redemption fee and the accounting treatment of the refinancing and warrant.
- Assess potential dilution from the 200,000-share warrant and any adjustment provisions.
- Review subsequent filings for borrowings, covenant compliance, liquidity, and any amendments to the facility.